Effect of anti-TNF-α on peritoneal endometrial implants of rats.

OBJECTIVE To evaluate the effect of anti-TNF-α in the treatment of endometrial implants in the peritoneum of rats. METHODS Endometrial implants were surgically induced in 120 female Wistar-Albino rats. The animals were randomly divided into four groups. Group C (n = 36) received an intraperitoneal injection of 0.2 ml of saline. Group L (n = 41) received a subcutaneous injection of 1mg/kg of leuprolide. Group I5 (n = 20) received a subcutaneous injection of 5mg/kg of monoclonal anti-tumor necrosis factor (TNF) a (infliximab). Group I10 (n = 20) received a subcutaneous injection of 10mg/kg of infliximab. The rats were sacrificed after 21 days to assess the size of the implants and the expression of TNF. RESULTS Treatment with leuprolide (group L) promoted an absolute reduction in the surface area of the implant when compared with group C (+14 mm vs. 0mm, p = 0.013) and group I10 (+14 mm vs. +5 Mm, p = 0.018). Likewise, a percentage reduction of surface area of the implant was observed comparing group L with group C (+33.3% vs. 0%, p = 0.005) and group I10 (+33.3% vs. +18.3%, p = 0.027). Treatment with infliximab was not able to decrease the surface area of the implants when compared with group C. The expression of TNF-α in groups L, I5 and I10 was lower than in group C (505.6 mm(2) vs. 660.5 mm(2) vs. 317.2 mm(2) vs. 2519.3 mm(2), respectively; p <0.001). CONCLUSION The anti-TNF-α therapy reduced the expression of TNF-α in endometriotic implants, but did not reduce the surface area of the lesion.

[1]  S. Ferrero,et al.  Current pharmacotherapy for endometriosis , 2010, Expert opinion on pharmacotherapy.

[2]  N. Bersinger,et al.  Correlation between symptoms of pain and peritoneal fluid inflammatory cytokine concentrations in endometriosis , 2009, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[3]  P. Vercellini,et al.  Medical treatment for rectovaginal endometriosis: what is the evidence? , 2009, Human reproduction.

[4]  J. C. Francisco,et al.  Development of an experimental model of endometriosis in rats. , 2009, Revista do Colegio Brasileiro de Cirurgioes.

[5]  D. Timmerman,et al.  Anti-TNF-α treatment for deep endometriosis-associated pain: a randomized placebo-controlled trial , 2008, Human reproduction.

[6]  T. D’Hooghe,et al.  Effects of anti-TNF-mAb treatment on pregnancy in baboons with induced endometriosis. , 2008, Fertility and sterility.

[7]  O. M. Torres,et al.  Modificações do volume e da histologia de focos de endometriose em ratas tratadas com sinvastatina , 2007 .

[8]  H. Zeyneloglu,et al.  High-dose atorvastatin causes regression of endometriotic implants: a rat model. , 2007, Human reproduction.

[9]  T. Falcone,et al.  Tumour necrosis factor-α blockers: potential limitations in the management of advanced endometriosis? A Case Report , 2006 .

[10]  M. Karagianni,et al.  Favorable response to subcutaneous administration of infliximab in rats with experimental colitis. , 2005, World journal of gastroenterology.

[11]  Robert Greb,et al.  ESHRE guideline for the diagnosis and treatment of endometriosis. , 2005, Human reproduction.

[12]  S. Bulun,et al.  Anastrazole and oral contraceptives: a novel treatment for endometriosis. , 2005, Fertility and sterility.

[13]  C. Dorn,et al.  Tumor necrosis factor alpha secretion by peritoneal macrophages in patients with endometriosis , 2005, Archives of Gynecology and Obstetrics.

[14]  S. Altunyurt,et al.  Regression of endometrial explants in rats treated with the cyclooxygenase-2 inhibitor rofecoxib. , 2004, Fertility and sterility.

[15]  R. Robinson,et al.  Efficacy of anti-tumor necrosis factor therapy in the treatment of spontaneous endometriosis in baboons. , 2004, Fertility and sterility.

[16]  A. Goumenou,et al.  Altered expression of interleukin-18 in the peritoneal fluid of women with endometriosis. , 2003, Fertility and sterility.

[17]  P. Vandekerckhove,et al.  Ovulation suppression for endometriosis. , 2003, The Cochrane database of systematic reviews.

[18]  A. Arıcı,et al.  Immunology and Endometriosis , 2003, American journal of reproductive immunology.

[19]  C. Kyama,et al.  Future directions in endometriosis research. , 2003, Obstetrics and gynecology clinics of North America.

[20]  N. Terakawa,et al.  Role of cytokines in endometriosis. , 2001, Fertility and sterility.

[21]  N. Terakawa,et al.  Tumor Necrosis Factor-α Promotes Proliferation of Endometriotic Stromal Cells by Inducing Interleukin-8 Gene and Protein Expression , 2000 .

[22]  A. Bukovsky,et al.  Regression of endometrial explants in a rat model of endometriosis treated with the immune modulators loxoribine and levamisole. , 1999, Fertility and sterility.

[23]  E. Baracat,et al.  Endometriose: modelo experimental em ratas , 1999 .

[24]  J. Kononen,et al.  Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.

[25]  Dong-bao Chen,et al.  Stimulation of prostaglandin (PG) F2α and PGE2 release by tumour necrosis factor-α and interleukin-1α in cultured human luteal phase endometrial cells , 1995 .

[26]  R. Wild,et al.  Effect of tumor necrosis factor-alpha on adhesion of human endometrial stromal cells to peritoneal mesothelial cells: an in vitro system. , 1993, Fertility and sterility.

[27]  J. Collins,et al.  Tumor necrosis factor in peritoneal fluid of women undergoing laparoscopic surgery. , 1988, Fertility and sterility.

[28]  M. Vernon,et al.  Studies on the surgical induction of endometriosis in the rat. , 1985, Fertility and sterility.

[29]  R. Jones.  The effect of a luteinizing hormone releasing hormone (LRH) agonist (Wy-40,972), levonorgestrel, danazol and ovariectomy on experimental endometriosis in the rat. , 1984, Acta endocrinologica.

[30]  Huan Song,et al.  Anti-TNF-alpha treatment for pelvic pain associated with endometriosis. , 2010, The Cochrane database of systematic reviews.

[31]  J. Jakowicki,et al.  [Expression of tumor necrosis factor-alpha (TNF-alpha) on peritoneal fluid mononuclear cells in women with endometriosis]. , 2008, Ginekologia polska.

[32]  T. Falcone,et al.  Tumour necrosis factor-alpha blockers: potential limitations in the management of advanced endometriosis? A case report. , 2006, Human reproduction.

[33]  F. Deer,et al.  Recombinant Human TNFRSF1A (r-hTBP1) Inhibits the Development of Endometriosis in Baboons: A Prospective, Randomized, Placebo- and Drug-Controlled Study1 , 2006, Biology of reproduction.

[34]  L. Story,et al.  Animal studies in endometriosis: a review. , 2004, ILAR journal.

[35]  D. Bullimore.  Endometriosis is sustained by tumour necrosis factor-α , 2003 .

[36]  M. Mueller,et al.  Immunobiology of endometriosis. , 2001, Fertility and sterility.

[37]  N. Terakawa,et al.  Tumor necrosis factor-alpha promotes proliferation of endometriotic stromal cells by inducing interleukin-8 gene and protein expression. , 2000, The Journal of clinical endocrinology and metabolism.

[38]  Z. M. Yang,et al.  Stimulation of prostaglandin (PG) F2 alpha and PGE2 release by tumour necrosis factor-alpha and interleukin-1 alpha in cultured human luteal phase endometrial cells. , 1995, Human reproduction.

[39]  F. Mantovani,et al.  Presence and rehabilitation: toward second-generation virtual reality applications in neuropsychology , 2004, Journal of NeuroEngineering and Rehabilitation.